Nephro Care India Discloses H1 Related Party Transactions
Nephro Care India Ltd · Others (Uncategorized) · 12 Nov 2026, 11:24 pm
Nephro Care India Discloses H1 Related Party Transactions Nephro Care India Ltd disclosed related party transactions for the half-year ended 30th Sep'26 under Regulation 23(9) of SEBI LODR. Key transactions included consultancy charges of ₹4.32 cr to Managing Director Pratim Sengupta (outstanding payable ₹86.40 lakh), operational revenue of ₹13.42 lakh from Sampurna Women Care and IFV (receivable ₹25.29 lakh), and blood consumables purchases worth ₹21.67 lakh from Arica Diagnostic Private Limited (payable ₹10.40 lakh). Remuneration to the CFO and Company Secretary stood at ₹16.00 lakh and ₹6.00 lakh, respectively.
Original exchange filing (PDF)
More announcements from Nephro Care India Ltd
- Nephro Care India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 12 Nov 2026
- Nephro Care India Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 12 Nov 2026
- Nephro Care India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 12 Nov 2026
- NEPHRO CARE INDIA LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 12 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 12 Nov 2026
- SDD Certificate for the quarter ended 30th September 2026 · 05 Oct 2026
- Nephro Care India Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the quarter ended 30th September 2026 · 01 Oct 2026
- Nephro Care India Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 25, 2026. Further, the company has informed the Exchange regarding voting results. · 28 Sept 2026
